SIRPA and neoplasm: CD47 is a transmembrane protein with high expression in tumor-initiating cells, where elevated CD47 expression will inhibit the phagocytosis of phagocytes via binding to its receptor, signal regulatory protein α (SIRPα) which is expressed on phagocytes, thereby making the tumor cells escape the tumor immune surveillance (28–30).